EGALOGNASTAT
UNII E9QIS63WUM

Substance Identification & Data

This profile provides standardized clinical and technical data for Egalognastat, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E9QIS63WUM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E9QIS63WUM

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EGALOGNASTAT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H21N5O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

PLUUAFJXXNCXSD-NSHDSACASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C215733

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

118903008

Unique identification number in the NCBI database of chemical substances.

INN ID

13548

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc([C@@H](N2CCN(c3nnc(NC(=O)C)s3)CC2)C)cc4c1OCO4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Egalognastat. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.